Cortisol and Depression: What Decades of Hormone Research Actually Show

Few ideas in wellness content are repeated as often as "depression is a cortisol problem." It is easy to see why. Cortisol is the body's main stress hormone, stress is a well-known trigger for depressive episodes, and people with conditions that flood the body with cortisol, such as Cushing's syndrome or long-term high-dose steroid treatment, often experience low mood. But the real research picture is more nuanced than a single hormone causing a single illness.

Scientists have studied the hypothalamic-pituitary-adrenal (HPA) axis, the brain-to-adrenal chain that controls cortisol release, in depression since the 1960s. A widely cited 2011 meta-analysis by Cinnamon Stetler and Gregory Miller in Psychosomatic Medicine pooled four decades of this work. On average, people with depression did show higher cortisol and other signs of HPA activation than people without depression, but the size of the difference varied a great deal between studies. The pattern tended to be stronger in older adults, in hospitalized patients, and in more severe forms such as melancholic or psychotic depression, and weaker or absent in many outpatients with milder symptoms.

That variability matters. It suggests that HPA changes are part of the story for some people with depression rather than a universal feature. Some research also finds the opposite pattern, with flattened or lower cortisol output in certain groups, such as people with atypical depression or long-term fatigue-related symptoms. Cause and effect are also hard to untangle: depression can disrupt sleep, appetite, and activity, all of which shift cortisol on their own, while sustained stress-hormone exposure may in turn affect brain regions involved in mood. Most researchers now describe the relationship as two-way.

This is why cortisol is not used to diagnose depression. In the 1980s, psychiatrists hoped the dexamethasone suppression test, which checks whether the body properly turns down cortisol production, might become a lab test for depression. It did not hold up well enough in everyday practice, because many people with depression had normal results and some people without it had abnormal ones. Drugs designed to block cortisol's effects have been tested as depression treatments, with mixed and mostly modest results, and they are not standard care. Established treatments such as psychotherapy and antidepressant medication remain the evidence-based options, and some studies suggest HPA measures may move toward normal as people recover.

There is also a skin angle. Depression is associated with several inflammatory skin conditions; a 2014 meta-analysis by Dowlatshahi and colleagues in the Journal of Investigative Dermatology found that people with psoriasis were more likely to report depressive symptoms than people without it. The connection likely runs in both directions, involving visible symptoms, itch, poor sleep, inflammation, and stress hormones, but research has not shown that cortisol alone explains it. If skin and mood problems are flaring together, mentioning both to your clinicians can help them address the full picture.

So what is proven and what is trend? Well supported: depression, especially severe depression, is associated on average with changes in HPA axis activity. Still uncertain: how much those changes cause symptoms versus result from them, and which people they apply to. Trend and marketing: supplements, teas, or programs that promise to "fix depression by lowering cortisol," and at-home cortisol tests sold as a way to diagnose mood problems. If you are struggling with low mood, a doctor or mental health professional is the right first step.